Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

Sending an “open letter” to President Trump has been in vogue these days. Social activists, business moguls, media chieftains and political leaders all have penned a multitude of them since the ...

Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

As 2025 kicks off there’s lots of activity in the world of IP – particularly in the Biotech and Pharma sectors, writes Marc Wilkinson, Partner with J A Kemp. We at J A Kemp LLP have plenty to talk ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

Prosecutors say one of the men arrested Tuesday was working with a crew alleged to be behind the December burglary at the ...

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

In an interview with THE WEEK, Professor Chuan He, lead researcher at the University of Chicago, talks about the new findings ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.